Kyntra Bio (KYNB) Stock Forecast & Price Target

$5.87 -0.25 (-4.08%)

Closing price 10/13/2026 04:00 PM Eastern

Extended Trading

$5.88 +0.00 (+0.09%)

As of 08:40 AM Eastern

Compare

Kyntra Bio - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold

Based on 7 Analyst Ratings

Sell
2

Hold
0

Buy
5

Based on 7 Wall Street analysts who have issued ratings for Kyntra Bio in the last 12 months, the stock has a consensus rating of "Hold." Out of the 7 analysts, 2 have given a sell rating, and 5 have given a buy rating for KYNB.

Consensus Price Target

$36.80
526.92% Upside

According to the 7 analysts' twelve-month price targets for Kyntra Bio, the average price target is $36.80. The highest price target for KYNB is $43.00, while the lowest price target for KYNB is $30.00. The average price target represents a forecasted upside of 526.92% from the current price of $5.87.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for KYNB and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kyntra Bio and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KYNB Analyst Ratings Over Time

Type	Current Forecast 10/14/25 to 10/14/26	1 Month Ago 9/14/25 to 9/14/26	3 Months Ago 7/16/25 to 7/16/26	1 Year Ago 10/14/24 to 10/14/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	1 Strong Buy rating(s)	N/A
Buy	5 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)	N/A
Hold	0 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	N/A
Sell	2 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	N/A
Consensus Price Target	$36.80	$36.00	$32.50	N/A
Forecasted Upside	526.92% Upside	348.32% Upside	339.78% Upside	N/A
Consensus Rating	Hold	Hold	Moderate Buy	N/A

KYNB Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

KYNB Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Kyntra Bio Stock vs. The Competition

Type	Kyntra Bio	Healthcare Companies	Broader Market
Consensus Rating Score	2.57	2.32	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	526.92% Upside	1,079.79% Upside	19.09% Upside
News Sentiment Rating	Positive News See Recent KYNB News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Show

Rating

Upside/Downside

Action

Report Date

0 Results

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
10/13/2026	Maxim Group 1 of 5 stars	Michael Okunewitch 1 of 5 stars	Initiated Coverage	Buy	$35.00	+471.89%
10/12/2026	Zacks Research 4 of 5 stars		Downgrade	Hold ➝ Strong Sell
10/9/2026	Weiss Ratings 3 of 5 stars		Downgrade	Sell (D+) ➝ Sell (D)
9/17/2026	Lake Street Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Daniel Brims Subscribe to MarketBeat All Access to unlock analyst rankings	Initiated Coverage	Buy	$41.00	+438.76%
9/1/2026	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Matthew Keller Subscribe to MarketBeat All Access to unlock analyst rankings	Reiterated Rating	Buy	$43.00	+452.70%
7/6/2026	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Jay Olson Subscribe to MarketBeat All Access to unlock analyst rankings	Initiated Coverage	Outperform	$35.00	+382.76%
6/9/2026	Rodman & Renshaw Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael King Subscribe to MarketBeat All Access to unlock analyst rankings	Initiated Coverage	Buy	$30.00	+352.49%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 08:46 AM ET.

KYNB Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Kyntra Bio is $36.80, with a high forecast of $43.00 and a low forecast of $30.00.

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kyntra Bio in the last twelve months. There are currently 2 sell ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" KYNB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KYNB, but not buy additional shares or sell existing shares.

According to analysts, Kyntra Bio's stock has a predicted upside of 526.92% based on their 12-month stock forecasts.

Over the previous 90 days, Kyntra Bio's stock had 2 downgrades and 1 upgrade by analysts.

Kyntra Bio has been rated by research analysts at HC Wainwright, Lake Street Capital, Maxim Group, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Kyntra Bio more than other "healthcare" companies. The consensus rating score for Kyntra Bio is 2.43 while the average consensus rating score for "healthcare" companies is 2.32. Learn more on how KYNB compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Kyntra Bio Recommendations

MarketBeat monitors more than a dozen sources for Kyntra Bio analyst ratings, with the most recent rating issued on 10/13/2026.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kyntra Bio (KYNB) Stock Forecast & Price Target

Kyntra Bio - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

KYNB Analyst Ratings Over Time

KYNB Analyst Recommendations By Month

KYNB Price Targets by Month

Kyntra Bio Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

KYNB Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Kyntra Bio Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Kyntra Bio (KYNB) Stock Forecast & Price Target

Kyntra Bio - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

KYNB Analyst Ratings Over Time

KYNB Analyst Recommendations By Month

KYNB Price Targets by Month

Kyntra Bio Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

KYNB Forecast - Frequently Asked Questions

What is Kyntra Bio's forecast for 2026?

Should I buy or sell Kyntra Bio stock right now?

Does Kyntra Bio's stock price have much upside?

Has Kyntra Bio been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Kyntra Bio?

Do Wall Street analysts like Kyntra Bio more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Kyntra Bio Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools